Market Cap 69.40M
Revenue (ttm) 90,000.00
Net Income (ttm) -68.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76,322.22%
Debt to Equity Ratio -1.65
Volume 908,900
Avg Vol 3,456,170
Day's Range N/A - N/A
Shares Out 50.29M
Stochastic %K 82%
Beta 2.27
Analysts Strong Sell
Price Target $6.76

Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term r...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 902 8800
Website: fractyl.com
Address:
3 Van de Graaff Drive, Suite 200, Burlington, United States
theThroatSlasher
theThroatSlasher Oct. 24 at 11:12 AM
$NEUP management is buying its own stock to prevent it from sliding off the damned edge into a precipice and joining goofs such as $GUTS back on Aug 6
0 · Reply
speculator
speculator Oct. 23 at 11:27 AM
$GUTS 683 Capital Management, LLC Increases Stake in Fractyl Health Inc https://www.gurufocus.com/news/3149119/683-capital-management-llc-increases-stake-in-fractyl-health-inc / https://www.sec.gov/Archives/edgar/data/1572616/000108514625005954/xslSCHEDULE_13G_X01/primary_doc.xml
0 · Reply
Mr_Pean
Mr_Pean Oct. 23 at 11:09 AM
$GUTS no need for maintenance GLP-1 shots for life! Revita addresses the root cause of obesity with a an outpatient procedure to provide durable weight maintenance for patients living with obesity!
0 · Reply
BioRich
BioRich Oct. 23 at 3:08 AM
$ALT $GUTS I love it when my biggest stalker tries to bash me and my picks, only to fall on their face... yet again. Thanks for trying to get cute with $GUTS. You know, $GUTS that is the only clinical trial treatment to RETAIN weight loss following GLP-1 discontinuation. That one. In a turn of beautiful fortune, $GUTS proceeded to gain 4.7% from the time of your ill-advised bash attempt. Oh, and went down 2.5%. So that means your EE is 7.2% on your embarrassing post. *EE - Effective Embarrassment For those looking to make money and not just join bagholding misery cults... Follow/ Subscribe for more suggestions and perspective. Would love to hear yours. Let's make some money. Cheers!
0 · Reply
Fede_Tech
Fede_Tech Oct. 21 at 11:24 AM
$GUTS Current value: $1.39 MA200: $1.49 If it breaks, it will explode. Simple as that.
0 · Reply
Mr_Pean
Mr_Pean Oct. 21 at 5:56 AM
$GUTS my kind of day!
0 · Reply
Fede_Tech
Fede_Tech Oct. 20 at 9:33 PM
$GUTS 6,412,201 shares held by Peter Thiel, which looks like it has found bottom.
0 · Reply
tmpl
tmpl Oct. 20 at 7:58 PM
$GUTS It is almost there
0 · Reply
BioRich
BioRich Oct. 17 at 7:57 PM
$ALT Imagine if you bought $NUAI when I suggested it. Keeps running. You'd have made back your losses multiple times over. Watch $IDYA after hours, and make sure you get some more $GUTS on the gift day. $SBFM has been a nice winner this week as well. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. Let's make some money. Cheers!
1 · Reply
Mr_Pean
Mr_Pean Oct. 15 at 11:56 PM
$GUTS was hoping for more out of today.
2 · Reply
Latest News on GUTS
Fractyl Health, Inc. - Special Call

Sep 26, 2025, 11:07 AM EDT - 4 weeks ago

Fractyl Health, Inc. - Special Call


Fractyl Health, Inc. (GUTS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 8:00 PM EDT - 2 months ago

Fractyl Health, Inc. (GUTS) Q2 2025 Earnings Call Transcript


Fractyl Health Announces Proposed Public Offering

Aug 5, 2025, 4:15 PM EDT - 2 months ago

Fractyl Health Announces Proposed Public Offering


Fractyl Health: Speculative Buy With Binary Risk

Jul 16, 2025, 10:13 AM EDT - 3 months ago

Fractyl Health: Speculative Buy With Binary Risk


Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:43 PM EDT - 5 months ago

Fractyl Health, Inc. (GUTS) Q1 2025 Earnings Call Transcript


Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 8:01 PM EST - 8 months ago

Fractyl Health, Inc. (GUTS) Q4 2024 Earnings Call Transcript


Fractyl Health to Participate in the Upcoming December Conferences

Nov 26, 2024, 7:00 AM EST - 11 months ago

Fractyl Health to Participate in the Upcoming December Conferences


Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:01 PM EST - 1 year ago

Fractyl Health, Inc. (GUTS) Q3 2024 Earnings Call Transcript


Fractyl Health, Inc. (GUTS) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 9:27 PM EDT - 1 year ago

Fractyl Health, Inc. (GUTS) Q2 2024 Earnings Call Transcript


theThroatSlasher
theThroatSlasher Oct. 24 at 11:12 AM
$NEUP management is buying its own stock to prevent it from sliding off the damned edge into a precipice and joining goofs such as $GUTS back on Aug 6
0 · Reply
speculator
speculator Oct. 23 at 11:27 AM
$GUTS 683 Capital Management, LLC Increases Stake in Fractyl Health Inc https://www.gurufocus.com/news/3149119/683-capital-management-llc-increases-stake-in-fractyl-health-inc / https://www.sec.gov/Archives/edgar/data/1572616/000108514625005954/xslSCHEDULE_13G_X01/primary_doc.xml
0 · Reply
Mr_Pean
Mr_Pean Oct. 23 at 11:09 AM
$GUTS no need for maintenance GLP-1 shots for life! Revita addresses the root cause of obesity with a an outpatient procedure to provide durable weight maintenance for patients living with obesity!
0 · Reply
BioRich
BioRich Oct. 23 at 3:08 AM
$ALT $GUTS I love it when my biggest stalker tries to bash me and my picks, only to fall on their face... yet again. Thanks for trying to get cute with $GUTS. You know, $GUTS that is the only clinical trial treatment to RETAIN weight loss following GLP-1 discontinuation. That one. In a turn of beautiful fortune, $GUTS proceeded to gain 4.7% from the time of your ill-advised bash attempt. Oh, and went down 2.5%. So that means your EE is 7.2% on your embarrassing post. *EE - Effective Embarrassment For those looking to make money and not just join bagholding misery cults... Follow/ Subscribe for more suggestions and perspective. Would love to hear yours. Let's make some money. Cheers!
0 · Reply
Fede_Tech
Fede_Tech Oct. 21 at 11:24 AM
$GUTS Current value: $1.39 MA200: $1.49 If it breaks, it will explode. Simple as that.
0 · Reply
Mr_Pean
Mr_Pean Oct. 21 at 5:56 AM
$GUTS my kind of day!
0 · Reply
Fede_Tech
Fede_Tech Oct. 20 at 9:33 PM
$GUTS 6,412,201 shares held by Peter Thiel, which looks like it has found bottom.
0 · Reply
tmpl
tmpl Oct. 20 at 7:58 PM
$GUTS It is almost there
0 · Reply
BioRich
BioRich Oct. 17 at 7:57 PM
$ALT Imagine if you bought $NUAI when I suggested it. Keeps running. You'd have made back your losses multiple times over. Watch $IDYA after hours, and make sure you get some more $GUTS on the gift day. $SBFM has been a nice winner this week as well. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. Let's make some money. Cheers!
1 · Reply
Mr_Pean
Mr_Pean Oct. 15 at 11:56 PM
$GUTS was hoping for more out of today.
2 · Reply
BioRich
BioRich Oct. 15 at 9:12 PM
$XBI Looks like yesterday's picks turned out pretty well, led by $SBFM. I see that continuing to run as it gets more attention. Could be a multi-bagger. Also, 1) $GUTS My #1 "Must Have" Bio. You thought Wegovy was a big deal, check out his beauty. Retains weight loss when you discontinue a GLP-1 and also has shown insane weight loss in early models using gene therapy (not their lead, but very exciting). Will be subject of massive BO/PS. 2) $IVA If you're interested in the MASH/Fibrosis/Liver space (which is increasingly becoming as popular as Obesity), this is your pick. P3 with impressive Fibrosis Improvement data. Expect them to get BO too. 3) Added more $GDRX. This was a great pick at these levels before the TrumpRX news. Still a great pick and will go parabolic if TrumpRx takes off and uses GDRX (No political posts, please). Follow/Subscribe for more suggestions/perspective. Would love to hear yours too. Let's make some money. Cheers!
1 · Reply
BioRich
BioRich Oct. 15 at 8:52 PM
$ALT Friendly reminder for those looking towards this ticker for the next big thing...RUN! The Bulls on this page spread misinformation and act like Uncle Rico about what could have been. They won't tell you the truth, but this company failed their trial, they have discontinued countless programs, they withhold data (while diluting) and are facing intense legal and securities fraud attention. Simple test...if it did 1/3 of what this board pumps "it does", this would be trading at $20/share. It's not, and for good reason. If you want in the MASH/fibrosis race, get some $IVA. If you want in the Obesity sector, invest as heavily as you possibly can in $GUTS. $VERU is an interesting one and $TERN continues to soar on the cusp on transformational data. Follow/Subscribe for more suggestions and pespective. Would love to hear yours too. That's how we find these gems (not ALT) and learn. Let's make some money. Cheers!
0 · Reply
Mr_Pean
Mr_Pean Oct. 14 at 4:49 AM
$GUTS I have been given advice that this is one of the best places to park your money. Double
0 · Reply
BioRich
BioRich Oct. 13 at 4:45 PM
$GUTS Nice entry point here. Could still drift towards $1.25 if we have a few market down days, but I'm comfortable with where we're at. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
0 · Reply
Mr_Pean
Mr_Pean Oct. 11 at 12:10 AM
$GUTS not a great week but I’m optimistic about next week.
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 5:42 PM
$GUTS Ever get bullied??? Trading stocks?? Me too!!! Well 🩳🔥🖕🔥🩳🔥🖕🔥🩳🖕
0 · Reply
Mr_Pean
Mr_Pean Oct. 10 at 4:35 AM
$GUTS was hoping for more out of today.
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 11:53 PM
Keep a close watch on CMCT! $OFAL $CAMP $GUTS $MNMD /
0 · Reply
BioRich
BioRich Oct. 9 at 9:34 PM
$XBI I believe the Super Deal that can happen, that will give BP a giant killer, would be someone going after $IVA $GUTS and $VERU. I think that deal could come in between $6-8B, with $100B total market share return potential. These numbers may be low, but I believe their realistic. Here's how I see it: $IVA - Fibrosis Improvement with other cardio-metabolic benefits. $GUTS - Weight Loss Retention following GLP-1 discontinuation + Gene Therapy for WL. $VERU - Lean Mass Preservation in combination of GLP-1. Obviously, no one called me, but looking at a Dream Team, I think this gets the job done. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
0 · Reply
StockTraderDrew
StockTraderDrew Oct. 9 at 7:23 PM
$GUTS still bullish in short/medium term. might take a few weeks to cook tho.
0 · Reply
Mr_Pean
Mr_Pean Oct. 8 at 11:43 PM
$GUTS I’ll take it.
0 · Reply
BanCrupt
BanCrupt Oct. 8 at 9:40 AM
$GUTS data release is not so impressive, which is probably why stock is down. relative to placebo, diet-induced obese mice lost 29% body weight from baseline in 35 days with RJVA-002. $VKTX's preclinical mouse model showed 28.4% reduction for VK2735 and 29.22% for Tirzepatide in 14 days. poster here https://vikingtherapeutics.com/wp-content/uploads/Yagiz_Novel-dual-incretin-receptor-agonists_Poster-207_20Oct2021-1.pdf see fig and tab 1. So RJVA-002 is not competitive in preclinical data at all. But it is a gene therapy, which is a unique MoA, so there is likely to be some value to it, probably for harder to treat patients with diabetes. remains to be seen how it performs in clinical trials with humans, which start in 2026. neither bearish nor bullish on this data, but it's not "good" data in context of existing or soon-to-market obesity treatments.
0 · Reply